menu
    • menu

    Find Pembrolizumab manufacturers, exporters & distributors on PharmaCompass

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    3

    API Suppliers

    API Suppliers

    0

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    0

    KDMF

    KDMF

    0

    NDC API

    NDC API

    0

    VMF

    NDC API

    3

    Listed Suppliers

    Other Suppliers

    0INTERMEDIATES

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    FINISHED DOSAGE FORMULATIONS

    41

    FDF Dossiers

    FDF Dossiers

    1

    FDA Orange Book

    FDA (Orange Book)

    2

    Europe

    Europe

    1

    Canada

    Canada

    36

    Australia

    Australia

    1

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    1123DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    19RELATED EXCIPIENT COMPANIES

    40EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    API REF. PRICE (USD/KG)

    $
    $ 0

    GLOBAL SALES INFORMATION

    US Medicaid

    116,820,430

    Annual Reports

    130,517

    Regulatory FDF Prices

    Listed Dossiers
    API/FDF Prices: Book a Demo to
    explore the features and consider
    upgrading later

    MARKET PLACE

    4

    API

    5

    FDF

    DIGITAL CONTENT

    6

    Data Compilation #PharmaFlow

    5

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    1248

    News #PharmaBuzz

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set

    API SUPPLIERS

    read-more
    read-more

    01

    Shanghai Minbiotech

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    IFT FIRST
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Shanghai Minbiotech CB

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Beijing Mesochem Technology

    China

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    CPhI WW Frankfurt
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothMesochem is focused on incessant innovation along with the R&D of new APIs.

    Contact Supplier Contact Supplier
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    Mesochem Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    KinBio

    Israel

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    IFT FIRST
    Not Confirmed
    arrow

    KinBio

    Israel

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    IFT FIRST
    Not Confirmed
    USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Europe

    read-more
    read-more

    01

    Merck Sharp & Dohme Limited

    U.S.A
    CRS
    Not Confirmed
    arrow

    Merck Sharp & Dohme Limited

    U.S.A
    arrow
    CRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Sweden

    pembrolizumab

    Brand Name : KEYTRUDA

    Dosage Form : POWDER FOR SOLUTION FOR INFUSION

    Dosage Strength : 50 MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Sweden

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    MSD Merck Sharp & Dohme AG

    U.S.A
    CRS
    Not Confirmed
    arrow

    MSD Merck Sharp & Dohme AG

    U.S.A
    arrow
    CRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info :

    Registration Country : Switzerland

    Pembrolizumab

    Brand Name : Keytruda

    Dosage Form : Inf Konz

    Dosage Strength : 100mg/4ml

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Switzerland

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    South Africa

    read-more
    read-more

    01

    MSD (Pty) Ltd

    U.S.A
    CRS
    Not Confirmed
    arrow

    MSD (Pty) Ltd

    U.S.A
    arrow
    CRS
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Originator

    Registration Country : South Africa

    Pembrolizumab

    Brand Name : Keytruda

    Dosage Form : INJ

    Dosage Strength : 25mg/ml

    Packaging : 4X1mg/ml

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Solubilizers

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Topical

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    STOCK RECAP #PipelineProspector

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    FDF DOSSIERS

    read-more
    read-more
    Bulgaria.png
    Tender// Pembrolizumab (25 mg/ ml in 4 ml) Injections needed in Bulgaria [ENA17853]
    Universitetska Mnogoprofilna Bolnitsa Za Aktivno Lechenie Tsaritsa Yoanna-Isul Ead is looking for supplies of ?embrolizumab (25 mg/ ml in 4 ml) Injections for commercial purposes. The required quantity is 3,510 units. The deadline is 13-Sept-2023.
    22 Aug 2023

    Reply

    22 Aug 2023

    Reply text-arrow

    Reply Comment (2)

    22 Aug 2023

    Brazil.png
    Various Finished Dosage Formulations needed in Brazil [ENA16235]
    A company that deals in the research, development & trading of health products is looking for suppliers of Various Finished Dosage Formulations for commercial purposes. The suppliers must support this enquiry with CTD Dossier. 1. Pembrolizumab (100 mg) Injections 2. Paclitaxel (6 mg, 30 mg, 100 mg, 150 mg & 300 mg) Injections 3. Nivolumab (40 mg & 100 mg) Injections 4. Oxaliplatin (5 mg, 50 mg & 100 mg) Injections 5. Bevacizumab (25 mg) Injections
    28 Jan 2023

    Reply

    28 Jan 2023

    Reply text-arrow

    Reply Comment (9)

    28 Jan 2023

    Poland.png
    Tender// Various Finished Dosage Formulations needed in Poland [ENA16189]
    Swietokrzyskie Centrum Onkologii Independent Public Health Care Center is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 21-Feb-2023. 1. Pembrolizumab (100 mg/ 4 ml) Solution for Infusions. The required quantity is 2,200 units. 2. Zoledronic Acid (4 mg/ 5 ml) Concentrate for Solution for Infusions. The required quantity is 900 units.
    24 Jan 2023

    Reply

    24 Jan 2023

    Reply text-arrow

    Reply Comment (2)

    24 Jan 2023

    Poland.png
    Tender// Various Finished Dosage Formulations needed in Poland [ENA09429]
    Wielkopolskie Center of Pulmonology and Thoracic Surgery Eugenia and Janusz Zeyland SP ZOZ is looking for suppliers of Various Finished Dosage Formulations. The deadline is 19-Jan-2021. 1. Teicoplanin (200 mg & 400 mg) Solution for Injection. The required quantity is 10 units for each. 2. Pembrolizumab (100 mg/ 4 ml) Solution for Injection. The required quantity is 230 units. 3. Atezolizumab (1200 mg/ 20 ml) Solution for Injection. The required quantity is 110 units. 4. Nintedanib (100 mg & 150 mg) Capsules. The required quantity is 15 units and 60 units respectively. 5. Mepolizumab (100 mg) Pen. The required is 30 units. 6. Mepolizumab (100 mg) Syringe. The required quantity is 10 units. 7. Amiodarone HCl (150 mg/ 3 ml) Ampoule in the packaging of 6 ampoules. The required quantity is 40 units. 8. Drotaverine HCl (40 mg/ 2 ml) Ampoule in the packaging of 5 ampoules. The required quantity is 40 units. 9. Tranexamic acid (500 mg/ 5 ml) Ampoule in the packaging of 5 ampoules. The required quantity is 150 units. 10. Rasburicase (1.5 mg) Vials in the packaging of 3 vials. The required quantity is 1 unit. 11. Enoxaparin Sodium (100 mg/ 1 ml, 20 mg/ 0.2 ml, 40 mg/ 0.4 ml, 60 mg/ 0.6 ml & 80 mg/ 0.8 ml). The required quantity is 60 units, 20 units, 900 units, 250 units and 200 units respectively.
    07 Jan 2021

    Reply

    07 Jan 2021

    Reply text-arrow

    Reply Comment (3)

    07 Jan 2021

    estonia.png
    Tender// Various Finished Dosage Formulations needed in Estonia [ENA09367]
    Sihtasutus Tartu Ülikooli Kliinikum is looking for supplies of Various Finished Dosage Formulations. The suppliers must support this tender with ESPD. The deadline is 25-Jan-2021. 1. Pertuzumab (420 mg) Concentration for Infusion. The required quantity is 450 units. 2. Pembrolizumab (100 mg) Powder for solution for Injection. The required quantity is 2,000 units. 3. Nivolumab (240 mg/ 24 ml) Concentration for Infusion. The required quantity is 480 units. 4. Obinutuzumb (1000 mg) Concentration for Infusion. The required quantity is 100 units. 5. Siponimodum (2 mg) Tablets. The required quantity is 1,000 units. 6. Upadacitinib (15 mg) Tablets. The required quantity is 2,000 units.
    29 Dec 2020

    Reply

    29 Dec 2020

    Reply text-arrow

    Reply Comment (8)

    29 Dec 2020

    PharmaCompass
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search